Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVID
1976
DELISTED
Avid Technology Inc
AVID
| $19.5M | ﹤0.01% |
673,283
-178,760
| -21% | -$5.52M |
|
1977
nLIGHT
LASR
$2.9B
| $19.4M | ﹤0.01% |
689,603
+15,614
| +2% | +$465K |
|
1978
Orion
OEC
$360M
| $19.4M | ﹤0.01% |
1,065,647
+81,804
| +8% | +$1.46M |
|
|
TGI
1979
DELISTED
Triumph Group
TGI
| $19.4M | ﹤0.01% |
1,040,681
+103,604
| +11% | +$1.93M |
|
|
IMGN
1980
DELISTED
Immunogen Inc
IMGN
| $19.4M | ﹤0.01% |
3,414,345
-218,231
| -6% | -$1.26M |
|
|
WOW
1981
DELISTED
WideOpenWest
WOW
| $19.4M | ﹤0.01% |
985,114
+79,754
| +9% | +$1.67M |
|
|
AMWD
1982
DELISTED
American Woodmark
AMWD
| $19.3M | ﹤0.01% |
295,674
-1,850
| -0.6% | -$136K |
|
1983
Coherus Oncology
CHRS
$176M
| $19.2M | ﹤0.01% |
1,197,784
+14,216
| +1% | +$208K |
|
|
PGTI
1984
DELISTED
PGT, Inc.
PGTI
| $19.2M | ﹤0.01% |
1,004,643
+5,096
| +0.5% | +$109K |
|
1985
Conduent
CNDT
$252M
| $19.2M | ﹤0.01% |
2,909,851
-18,054
| -0.6% | -$124K |
|
1986
Arcturus Therapeutics
ARCT
$223M
| $19.1M | ﹤0.01% |
400,369
+16,752
| +4% | +$751K |
|
1987
Griffon
GFF
$4.8B
| $19.1M | ﹤0.01% |
776,022
-5,017
| -0.6% | -$120K |
|
1988
Smith & Wesson
SWBI
$643M
| $19M | ﹤0.01% |
915,649
-4,687
| -0.5% | -$113K |
|
1989
Varex Imaging
VREX
$780M
| $19M | ﹤0.01% |
673,929
+8,886
| +1% | +$246K |
|
1990
Schneider National
SNDR
$6.37B
| $19M | ﹤0.01% |
834,571
+28,376
| +4% | +$627K |
|
|
AGEN
1991
Agenus
AGEN
$315M
| $19M | ﹤0.01% |
184,152
+11,617
| +7% | +$1.31M |
|
1992
Employers Holdings
EIG
$871M
| $19M | ﹤0.01% |
480,478
-3,613
| -0.7% | -$148K |
|
|
HA
1993
DELISTED
Hawaiian Holdings, Inc.
HA
| $19M | ﹤0.01% |
875,774
+15,996
| +2% | +$328K |
|
1994
Enanta Pharmaceuticals
ENTA
$391M
| $19M | ﹤0.01% |
333,793
+3,384
| +1% | +$167K |
|
|
HEES
1995
DELISTED
H&E Equipment Services
HEES
| $18.9M | ﹤0.01% |
545,814
+5,237
| +1% | +$174K |
|
1996
Clear Channel Outdoor Holdings
CCO
$1.18B
| $18.9M | ﹤0.01% |
6,976,862
+23,134
| +0.3% | +$57.7K |
|
|
LADR
1997
Ladder Capital
LADR
$1.27B
| $18.9M | ﹤0.01% |
1,710,890
-308,083
| -15% | -$3.45M |
|
1998
Nurix Therapeutics
NRIX
$2.82B
| $18.9M | ﹤0.01% |
630,698
+235,941
| +60% | +$7.28M |
|
1999
Center Bancorp
CNOB
$1.81B
| $18.9M | ﹤0.01% |
629,505
+13,434
| +2% | +$371K |
|
|
SCS
2000
DELISTED
Steelcase
SCS
| $18.8M | ﹤0.01% |
1,483,433
+4,250
| +0.3% | +$58.6K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.